SonoScape Medical Corp. (300633.SZ) has a MoatMap StockRank of 31/100 based on Quality (58/100), Value (27/100), and Momentum (33/100) factor scores. The current signal is SELL. SonoScape Medical is a high-quality medical device manufacturer (ultrasound and endoscopy). While it has solid fundamentals, it lacks direct alignment with our core macro themes for the next 18 months.
SonoScape Medical Corp. develops, manufactures, and distributes medical diagnostic equipment, specializing in high-end color Doppler ultrasound systems and flexible endoscopy solutions. The company's competitive moat is anchored in its strong R&D pipeline and proprietary imaging algorithms, allowing it to compete directly with multinational medical device giants. It is a leading domestic player in China's medical imaging sector with a rapidly expanding global distribution network.
| Price | $2.80 |
| Market Cap | $1.3B |
| P/E (TTM) | 47.93 |
| P/E (Forward) | 20.26 |
| Price/Book | 2.65 |
| Return on Equity | 5.6% |
| Return on Invested Capital | 5.0% |
| Debt/Equity | 8.44 |
| Gross Margin | 59.9% |
| Operating Margin | 0.8% |
| Revenue Growth | 11.8% |
| Dividend Yield | 0.9% |
| Free Cash Flow | $-668K |
SonoScape Medical Corp. operates in the Medical Devices industry, part of the Healthcare sector (China).